Literature DB >> 18767818

Dry HCl in parallel synthesis of fused pyrimidin-4-ones.

Andrey V Bogolubsky1, Sergey V Ryabukhin, Andrey S Plaskon, Svetlana V Stetsenko, Dmitriy M Volochnyuk, Andrey A Tolmachev.   

Abstract

The parallel solution-phase synthesis of substituted thieno[2,3- d]pyrimidin-6-carboxylic acids has been accomplished. This strategy relies on a cyclization of 2-aminothiophen-3,5-dicarboxylates with a set of nitriles, followed by hydrolysis to construct the library of corresponding acids. The convenient procedure for use and dosage of dry HCl for the reaction was elaborated and adapted for semiautomated solution-phase parallel synthesis. With the use of another (hetero)aromatic ortho-aminocarboxylate, mini-libraries of diverse fused pyrimidin-4-ones were synthesized. The scope and limitations of the approach are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18767818     DOI: 10.1021/cc800074t

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  4 in total

1.  Cyanoacetamide MCR (III): three-component Gewald reactions revisited.

Authors:  Kan Wang; Dabin Kim; Alexander Dömling
Journal:  J Comb Chem       Date:  2010 Jan-Feb

2.  Metal-free synthesis of 1,4-benzodiazepines and quinazolinones from hexafluoroisopropyl 2-aminobenzoates at room temperature.

Authors:  Jiewen Chen; En Liang; Jie Shi; Yinrong Wu; Kangmei Wen; Xingang Yao; Xiaodong Tang
Journal:  RSC Adv       Date:  2021-01-28       Impact factor: 3.361

3.  Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents.

Authors:  Farhana Islam; Arpit Doshi; Andrew J Robles; Tasdique M Quadery; Xin Zhang; Xilin Zhou; Ernest Hamel; Susan L Mooberry; Aleem Gangjee
Journal:  Molecules       Date:  2022-01-05       Impact factor: 4.411

4.  Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study.

Authors:  Fatma M Elmenier; Deena S Lasheen; Khaled A M Abouzid
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.